About Lee Pharma Limited
Data last updated:
Lee Pharma Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 06 October 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1997PLC028095. Its GSTIN is 36AAACC8372L1ZB (Telangana). The company holds 7 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹7.65 Cr and a paid-up capital of ₹1.64 Cr. It was formerly known as Lee Pharma Private Limited. It is led by directors including Venkata Reddy Alla (Managing Director) and Alla Ratna Kumari (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹928.7 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹35.52 Cr (net margin 3.8%) and EBITDA of ₹123.2 Cr (EBITDA margin 13.3%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 23% over five years.
The company has about 1,381 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Lee Pharma. As per MCA filings, the company has open charges of ₹592.69 Cr and satisfied charges of ₹518.66 Cr on record. Court records list 49 cases involving the company, including 23 filed by the company and 26 filed against it; 8 cases are pending. The company has 15 deals on record (11 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹25.32 Cr; the latest was in February 2024. Its 8 peer companies in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Biocon Pharma Limited with revenue of ₹982.5 Cr. The company has 16 MSME Form 1 returns on record between 2017 and 2024, listing 1,942 overdue payments to 84 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website leepharma.com.
Company details
CIN history
Lee Pharma has one previous CIN (Corporate Identification Number): U24230AP1997PLC028095. The current CIN is U24230TG1997PLC028095, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG1997PLC028095 | Current |
| U24230AP1997PLC028095 | Previous |
Contact details
Lee Pharma Limited's registered office is in Hyderabad, Telangana. Its website is leepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSurvey No.257&258/1 Door No.11 – 6/56 C Block Opp.Idpl Factory Moosapet(Village) Balan, Agar(Post), Hyderabad, Telangana, India – 500037
- IndustryPharma, API Manufacturers, Drug Formulation & Development
To see the full contact details of Lee Pharma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Lee Pharma operates one associated brand: Lee Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company focused on providing APIs, intermediates, and finished dosage forms | leepharma.com |
Business activity
The main business activity of Lee Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lee Pharma Limited, buy the company report.
Financials of Lee Pharma Limited
FY 2025 filings availableLee Pharma Limited reported revenue of ₹928.7 Cr (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 3% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹928.7 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹123.2 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹35.52 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.3% | ||||
| Net Profit Margin | 3.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lee Pharma Limited, buy the company report.
Board of directors of Lee Pharma Limited
Lee Pharma has 8 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alla Ratna Kumari Also directs: Lee Health Domain India Private Limited | Whole-Time Director | 27 Aug 2007 | 19 Years 1 Months | Current |
| Venkata Reddy Alla Also directs: Lee Health Domain India Private Limited | Managing Director | 06 Oct 1997 | 29 Years 0 Months | Current |
| Santosh Babu Busani Also directs: Hetero Healthcare Limited | Director | 30 Sep 2021 | 5 Years 0 Months | Current |
| Vijaykumar Raghunandanprasad Agrawal | Director | 27 Sep 2007 | 19 Years 0 Months | Current |
| Raghumitra Alla Also directs: Lee Fine Chem Private Limited | Whole-Time Director | 04 May 2006 | 20 Years 5 Months | Current |
| Dr Gopala Rao Tatineni Also directs: Vanastali Hills Real Estates Private Limited | Director | 22 Apr 1999 | 27 Years 6 Months | Current |
Peer comparison
Lee Pharma Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biocon Pharma Limited | ₹982.5 Cr (FY 2025) | 11.0% | Bangalore, Karnataka, India | |||
| Chemspec Chemicals Private Limited | ₹974.7 Cr (FY 2025) | 0.0% | Navi Mumbai, Maharashtra, India | |||
| Orchid Pharma Limited | ₹949.4 Cr (FY 2025) | 12.0% | Chengalpattu, Tamil Nadu, India | |||
| Fresenius Kabi India Private Limited | ₹934 Cr (FY 2025) | 10.0% | Ranjangaon, Maharashtra, India | |||
| Lee Pharma Limitedthis company | ₹928.7 Cr (FY 2025) | ₹35.52 Cr | 3.8% | 3.0% | 1,381 | Hyderabad, Telangana, India |
| Punjab Chemicals and Crop Protection Limited | ₹901.95 Cr (FY 2025) | -4.0% | Derabassi, Punjab, India | |||
| Omniactive Health Technologies Limited | ₹897.07 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Rubicon Research Limited | ₹872.39 Cr (FY 2024) | 108.0% | Thane, Maharashtra, India | |||
| Hindys Lab Private Limited | ₹857.52 Cr (FY 2025) | -9.0% | Chityal, Telangana, India |
To see the full peer comparison of Lee Pharma Limited, buy the company report.
Auditor
Lee Pharma Limited is audited by Suryanarayana Reddy & Co for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Suryanarayana Reddy & Co | FY 2025 | 005752S |
Shareholding
The shareholding of Lee Pharma Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Lee Pharma Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 May 2025 | 101099379 | Others | ₹15 Cr | Open | |
| 29 Mar 2025 | 101082310 | Others | ₹18 Cr | Open | |
| 17 May 2024 | 100936760 | Axis Bank Limited | ₹12.5 Cr | Open | |
| 19 May 2023 | 100727305 | Others | ₹30 Cr | Open | |
| 19 May 2023 | 100727323 | Others | ₹5 Cr | Open |
To see the full charge records of Lee Pharma Limited, buy the company report.
Total charge records: 44 View all charges
Deals & funding
Lee Pharma Limited has 15 deals on record (11 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹25.32 Cr; the latest was in February 2024.
Deals on record (5 of 15)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2024 | Rights issue | ₹27.08 Cr | Investors: R.L.Fine Chem Private Limited , 3 individuals |
| Jul 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2018 | Secondary share transfer | Undisclosed | Buyer: R.L.Fine Chem Private Limited Seller: MAPE Group |
| Feb 2018 | Secondary share transfer | Undisclosed | Buyer: R.L.Fine Chem Private Limited Seller: an individual |
| Apr 2017 | Secondary share transfer | Undisclosed | Buyer: R.L.Fine Chem Private Limited Seller: an individual |
To see the full deal history of Lee Pharma Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Lee Pharma Limited has 49 court cases on record: 23 filed by Lee Pharma, 26 filed against it. 8 cases are pending and 41 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 30 | 17 | 4 |
| District courts | 18 | 8 | 3 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (5 of 49)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (1101-Compensation : Motor vehicle accident compensation) | Filed against the company by Bajaj Allianz General Insurance Co. Ltd. | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
| District court, South Twenty Four Parganas, West Bengal | Criminal complaint | Filed against the company by Trireme Life Sciences Pvt. Limited | Disposed |
| High Court, TAMIL NADU | Appeal | Filed against the company by Symed Labs Limited | Disposed |
| High Court, TAMIL NADU | Appeal | Filed by the company against Symed Labs Limited | Disposed |
To see the full case history of Lee Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Lee Pharma Limited was last rated by Crisil on 24 Jun 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 24 Jun 2020 |
To see the full credit ratings and regulatory alerts of Lee Pharma Limited, buy the company report.
MSME payment delays
Lee Pharma Limited has 16 MSME Form 1 returns on record between 2017 and 2024, listing 1,942 overdue payments to 84 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 84)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Sai Siri Packaging Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Lee Pharma Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Lee Pharma Limited has a workforce of 1,381 employees on its EPFO records as of Oct 11, 2025, across 2 active EPFO establishments.
GST
Lee Pharma has 7 GST registrations: 5 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACC8372L1ZB | Telangana | Active | 01 Jul 2017 |
| 36AAACL3435F1ZT | Telangana | Active | 01 Jul 2017 |
| 36AAACL3435F2ZS | Telangana | Active | 24 Aug 2020 |
| 37AAACL3435F1ZR | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lee Pharma Limited, buy the company report.
Recent activity
Lee Pharma Limited has 18 board changes on record since 1997: 13 appointments and 5 cessations. The latest: Ramaseshappa Siva Prasad Panchangam was appointed as Director on 30 Sep 2024.
97 earlier events are in the company report.
News
Frequently asked questions
Lee Pharma is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 06 October 1997 (29+ years old) and is registered under CIN U24230TG1997PLC028095.
Lee Pharma has 8 current directors:
- Venkata Reddy Alla - Managing Director
- Alla Ratna Kumari - Whole-Time Director
- Raghumitra Alla - Whole-Time Director
- Santosh Babu Busani - Director
- Vijaykumar Raghunandanprasad Agrawal - Director
- Dr Gopala Rao Tatineni - Director
- Ramaseshappa Siva Prasad Panchangam - Director
- Anil Jain - Nominee Director
The latest financial statements of Lee Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lee Pharma is 36AAACC8372L1ZB, registered in Telangana. The company has 7 GST registrations in all, of which 5 are active and 2 are cancelled or inactive. Other active GSTINs include 36AAACL3435F1ZT (Telangana), 36AAACL3435F2ZS (Telangana), 37AAACL3435F1ZR (Andhra Pradesh).
The CIN (Corporate Identification Number) of Lee Pharma is U24230TG1997PLC028095. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lee Pharma has 49 court cases on record: 23 filed by the company and 26 filed against it. 8 are pending. Most are in the high courts.
Lee Pharma was incorporated on 06 October 1997, making it 29+ years old. It is registered with the Registrar of Companies, Hyderabad.
Lee Pharma has 15 deals on record (11 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹25.32 Cr; the latest was in February 2024.
The peers of Lee Pharma by revenue are Biocon Pharma Limited, Chemspec Chemicals Private Limited, Orchid Pharma Limited, Fresenius Kabi India Private Limited, Punjab Chemicals and Crop Protection Limited and 3 more, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ramaseshappa Siva Prasad Panchangam was appointed as Director on 30 Sep 2024. Anil Jain was appointed as Nominee Director on 29 Jul 2023. Vishakha Bhupendra Dhablia ceased to be Director on 29 Jul 2023. Lee Pharma has 18 board changes on record in total.
Lee Pharma has 16 MSME Form 1 returns on record between 2017 and 2024, listing 1,942 overdue payments to 84 micro and small suppliers. The latest return was filed on 28 May 2024.
Lee Pharma can be reached through the website leepharma.com. Its registered office is in Hyderabad, Telangana, India.